BioCentury
ARTICLE | Financial News

CymaBay amends follow-on

July 21, 2014 7:00 AM UTC

CymaBay Therapeutics Inc. (NASDAQ:CBAY), Newark, Calif. Business: Endocrine/Metabolic Date announced: 2014-07-17 Type: Follow-on To be raised: TBD Shares: 3.5 million Price prior: $7 Underwriters: Cow...